Recombinant Human Dual 3′,5′-cyclic-AMP and -GMP phosphodiesterase 11A (PDE11A), Truncated

Uniprot Id

Q9HCR9

Target Species

Human

Target Name

PDE11A

Target Full Name

Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A

Target Function

Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides cAMP and cGMP. Catalyzes the hydrolysis of both cAMP and cGMP to 5'-AMP and 5'-GMP, respectively.

Target Involvement

Primary pigmented nodular adrenocortical disease 2 (PPNAD2)

Target Subcellular Location

Cytoplasm, cytosol.

Target Protein Families

Cyclic nucleotide phosphodiesterase family

Target Tissue Specificity

Isoform 1 is present in prostate, pituitary, heart and liver. It is however not present in testis nor in penis, suggesting that weak inhibition by Tadalafil (Cialis) is not relevant (at protein level). Isoform 2 may be expressed in testis. Isoform 4 is ex

Target Synonyms

5''-cyclic-AMP and -GMP phosphodiesterase 11A; cAMP and cGMP phosphodiesterase 11A; cGMP phosphodiesterase 11A; Cyclic nucleotide phosphodiesterase 11A; Dual 3''; Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A; pde11; PDE11_HUMAN; pde11a; PDE11A1; pde11a2; Phosphodiesterase 11A; PPNAD2

Target Background

The 3', 5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3', 5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene.